<DOC>
	<DOCNO>NCT01725841</DOCNO>
	<brief_summary>Resistance broad-spectrum cephalosporin acquisition expression Extended-Spectrum β-lactamase ( ESBL ) among Enterobacteriacea increase . The clinical implication ESBLs extremely serious sensitive diagnostic method urgently need guide therapy , monitor resistance development implement intervention strategy . Conventionally , detection expression ESBLs base reduction ceftazidime cefotaxime MICs ≥ 3 two fold dilution presence clavulanic acid . However , use method limit cover bacterial specie , include predominantly E. coli Klebsiella spp. , test strain transconjugants generate vitro . ESBLs report grow number genus E. coli Klebsiella spp. , Serratia marcescens . Carbapenems , include ertapenem , imipenem meropenem , drug choice use severe ESBL-producing bacterial infection . Failure detect ESBL presence AmpC β-lactamase might result important clinical concern 4th generation cephalosporin , stable AmpC β-lactamase , drug choice severe infection cause ESBLs-producing isolates . Fluoroquinolone-resistance ESBL-producing Enterobacteriacea common . In study , investigator use isolates Enterobacteriacea collect different hospital ( isolates offer Taiwan Surveillance Antimicrobial Resistance [ TSAR ] program ) investigate susceptibility ertapenem five antimicrobial agent ESBLs-producing Enterobacteriacea .</brief_summary>
	<brief_title>The Prevalence Extend-Spectrum β-Lactamase ( ESBL ) Producing Isolates Among Common Enterobacteriaceae Taiwan</brief_title>
	<detailed_description>Materials Methods 1 . Collection bacterial isolate The staff National Health Research Institute establish long term surveillance antimicrobial resistance 22 44 hospital distribute part Taiwan-Taiwan Surveillance Antimicrobial Resistance ( TSAR ) since 1998 . It conduct five time year 1998 , 2000 , 2002 , 2004 , 2006 name TSAR-I , TSAR-II , TSAR-III , TSAR-IV TSAR-V . In study , isolate Enterobacteriaceas TSAR-IV recruit . Each 50 isolates Escherichia coli , Klebsiella pneumoniae , Proteus mirabilis , Enterobacter cloaca , Serratia marcescens , Morganella morganii enrol ( 10 % TSAR IV collect isolates ) follow microbiological study . Isolates divide ESBL-producing non-producing group screen test . All available isolates identify specie genus level mean conventional method . Isolates specie recover individual patient , consider one isolate . The isolates store -70℃ trypticase soy broth ( Difco Laboratories , Detroit , MI ) supplement 15 % glycerol test . 2 . Data Collection Information collect isolate include : collection date , test date , identification , site infection , hospital unit patient , whether isolate acquire community ( i.e. , specimen obtain &lt; 48 hour admission ) , length patient 's hospital stay . The susceptibility isolate targeted antimicrobial agent determine Minimum Inhibitory Concentration ( MIC value ) follow CLSI breakpoints respective antimicrobial agent . 3 . Antimicrobial susceptibility test - Inoculums preparation Sterile saline ( 0.85 % NaCl ) , suitable buffer broth inoculums preparation , depend organism . The CLSI inoculum procedure aerobes microorganism use . 0.5 McFarland turbidity use standard aerobe . - Inoculation Use sterile loops/swabs obtain optimal amount inoculum suspension . Swab entire agar surface three time ; rotate plate approximately 90 degree time ensure even distribution inoculum . Allow excess moisture absorb 10-15 minute surface completely dry apply E test strip . - Application E test strip Ensure inoculate agar surface completely dry apply E test strip . Use Etest applicator use forceps grip handle strip ( labeled E ) place inoculate agar surface , ensure MIC scale facing upwards concentration maximum near rim plate . Make sure whole strip complete contact agar surface . Once apply , strip move instantaneous release antibiotic agar . It recommend apply 4-6 different E test strip onto 150 agar plate . In study , E test strip six antimicrobial agent , include cefepime , cefepime plus clavulanic acid ( identification ESBL produce isolates ) , ciprofloxacin , cefmetazole , amikacin , tigecycline apply addition ertapenem . - Incubation The incubation temperature atmosphere use must optimal growth particular bacterial specie antibiotic test . CLSI recommend 35℃/16-18 hours/ambient atmosphere non-fastidious aerobe facultative anaerobe . - Reading MIC After complete period incubation bacterial growth become distinctly visible , read MIC value point intersection inhibition ellipse edge E test strip . Use E test reading Guide technical guide correctly read different pattern . Etest strip ( AB Biodisk , Solna , Sweden ) contain cefepime ( MIC test range , 0.25-16 mg/L ) cefepime ( MIC test range , 0.064-4 mg/L ) plus 4 mg/L clavulanic acid use detect expression ESBL accord manufacturer 's instruction.reduction MIC ≥3 two-fold dilution presence clavulanic acid indicator ESBL production . Deformation ellipses presence `` phantom '' zone also indicator ESBL production even MIC ratio &lt; 8 read . - Quality control In order check system respect correct handing , quality consistency material method , test quality control strain antibiotic concerned . S. pneumoniae H. influenzae determine broth microdilution ambient incubation . The following organism include control strain : S. aureus ATCC 29213 , E. faecalis ATCC 29212 , S. pneumoniae ATCC 49619 , E. coli ATCC 25922 , E. coli ATCC 35218 , K. pneumoniae ATCC 700603 , P. aeruginosa ATCC 27853 . For every 500 Etests perform , control test include 5 control strain do . - Molecular study Isolates expression ESBLs type use Pulsed field gel electrophoresis ( PFGE ) method . The detailed procedure PFGE interpretation PFGE band pattern description previous report ( 13 ) . Data Analysis Isolates categorize susceptible , intermediate , resistant accord guideline provide CLSI . Isolates intermediate resistant antimicrobial agent also categorize nonsusceptible agent . The rate nonsusceptibility among major bacterial pathogen analyze accord different site infection origin isolates . The association geographic area , hospital type isolates obtain antimicrobial susceptibility analyze .</detailed_description>
	<mesh_term>Enterobacteriaceae Infections</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>To determine prevalence ESBL-producing among Enterobacteriaceae isolates Taiwan</keyword>
	<keyword>To determine susceptibility ertapenem antimicrobial agent Enterobacteriaceae isolate without expression ESBLs</keyword>
	<keyword>To determine molecular type Enterobacteriaceae isolate expression ESBLs</keyword>
	<keyword>To analyze association geographic area , hospital type antimicrobial susceptibility</keyword>
</DOC>